Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

NeuroPace Inc

NPCE · Nasdaq · CIK 0001528287 · Healthcare · Medical Devices

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

21 Form 4 transaction lines observed in the same window
0 sales · 21 option, withholding, award, gift or other lines

Last qualifying purchase2022-11-22 · Accelmed Partners II L.P. · $93.6K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesNone
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Morrell MarthaCHIEF MEDICAL OFFICER
○○○○○
Becker JoelCHIEF EXECUTIVE OFFICER
○○○○○
Kumar RakhiDirector
○○
Geiger UriDirector
○○
Fischer Frank MDirector
○○
Williams Patrick F.Chief Financial Officer
○○
● Purchase▼ Sale○ Other

Showing the six most active owners; 3 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2022-11-22 · Accelmed Partners II L.P..

Recent Form 4 activity

0Purchases
1Sales
39Other Form 4 lines
39SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER21 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
903,626
Previous report
956,221
Avg daily volume
146,303
Days to cover
6.2

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2022-11-22Accelmed Partners II L.P.Purchase (P)Common Stock62,398USD 1.50USD 93,597SEC filing ↗
2022-11-21Accelmed Partners II L.P.Purchase (P)Common Stock327,893USD 1.50USD 491,840SEC filing ↗
2021-04-21Ridley IrinaPurchase (P)Common Stock2,352USD 17.00USD 39,984SEC filing ↗
2021-04-21ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLCPurchase (P)Common Stock235,000USD 17.00USD 3,995,000SEC filing ↗
2021-04-21Norton EvanPurchase (P)Common Stock588,235USD 17.00USD 9,999,995SEC filing ↗
2021-04-21Garfield Greg ShawPurchase (P)Common Stock13,235USD 17.00USD 224,995SEC filing ↗
2021-04-21Fischer Frank MPurchase (P)Common Stock50,000USD 17.00USD 850,000SEC filing ↗
2021-04-21Accelmed Partners II L.P.Purchase (P)Common Stock588,235USD 17.00USD 9,999,995SEC filing ↗

Form 4 evidence

40 transaction lines in the latest 365-day window; 268 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-24Morrell MarthaTax withholding (F)Common Stock335USD 13.97USD 4,680SEC filing ↗
2026-09-20Williams Patrick F.Tax withholding (F)Common Stock1,162USD 14.28USD 16,593SEC filing ↗
2026-09-03Becker JoelTax withholding (F)Common Stock1,310USD 14.75USD 19,322SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-24Morrell MarthaTax withholding (F)Common Stock335USD 13.97USD 4,680SEC filing ↗
2026-09-20Williams Patrick F.Tax withholding (F)Common Stock1,162USD 14.28USD 16,593SEC filing ↗
2026-09-03Becker JoelTax withholding (F)Common Stock1,310USD 14.75USD 19,322SEC filing ↗
2026-08-27Morrell MarthaTax withholding (F)Common Stock358USD 14.13USD 5,059SEC filing ↗
2026-08-27Becker JoelTax withholding (F)Common Stock1,126USD 14.13USD 15,910SEC filing ↗
2026-06-24Morrell MarthaTax withholding (F)Common Stock335USD 16.22USD 5,434SEC filing ↗
2026-06-19Kumar RakhiAward / grant (A)Common Stock989USD 15.63USD 15,458SEC filing ↗
2026-06-19Geiger UriAward / grant (A)Common Stock789USD 15.63USD 12,332SEC filing ↗
2026-06-19Fischer Frank MAward / grant (A)Common Stock1,467USD 15.63USD 22,929SEC filing ↗
2026-06-05Ryan ReneeAward / grant (A)Common Stock2,890USD 0.00USD 0SEC filing ↗
2026-06-05Kumar RakhiAward / grant (A)Common Stock2,890USD 0.00USD 0SEC filing ↗
2026-06-05Huennekens R ScottAward / grant (A)Common Stock2,890USD 0.00USD 0SEC filing ↗
2026-06-05Geiger UriAward / grant (A)Common Stock2,890USD 0.00USD 0SEC filing ↗
2026-06-05Fischer Frank MAward / grant (A)Common Stock2,890USD 0.00USD 0SEC filing ↗
2026-06-05Andrade LisaAward / grant (A)Common Stock2,890USD 0.00USD 0SEC filing ↗
2026-06-03Becker JoelTax withholding (F)Common Stock1,255USD 15.88USD 19,929SEC filing ↗
2026-05-27Morrell MarthaTax withholding (F)Common Stock358USD 17.06USD 6,107SEC filing ↗
2026-05-27Becker JoelTax withholding (F)Common Stock1,126USD 17.06USD 19,210SEC filing ↗
2026-05-15Williams Patrick F.Award / grant (A)Common Stock16,820USD 0.00USD 0SEC filing ↗
2026-05-15Morrell MarthaAward / grant (A)Common Stock5,460USD 0.00USD 0SEC filing ↗
2026-05-15Becker JoelAward / grant (A)Common Stock45,880USD 0.00USD 0SEC filing ↗
2026-03-24Morrell MarthaTax withholding (F)Common Stock1,341USD 13.27USD 17,795SEC filing ↗
2026-03-20LACOB JOSEPHAward / grant (A)Common Stock865USD 13.00USD 11,245SEC filing ↗
2026-03-20Geiger UriAward / grant (A)Common Stock913USD 13.00USD 11,869SEC filing ↗
2026-03-20Kumar RakhiAward / grant (A)Common Stock1,153USD 13.00USD 14,989SEC filing ↗
2026-03-20Fischer Frank MAward / grant (A)Common Stock1,826USD 13.00USD 23,738SEC filing ↗
2026-03-03Morrell MarthaTax withholding (F)Common Stock1,340USD 13.83USD 18,532SEC filing ↗
2026-03-03Becker JoelTax withholding (F)Common Stock5,023USD 13.83USD 69,468SEC filing ↗
2026-02-27Morrell MarthaTax withholding (F)Common Stock358USD 14.58USD 5,220SEC filing ↗
2026-02-27Becker JoelTax withholding (F)Common Stock1,126USD 14.58USD 16,417SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerNPCE
CIK0001528287
SectorHealthcare
IndustryMedical Devices Yahoo Finance
SEC SIC3841 Surgical & Medical Instruments & Apparatus
ExchangeNasdaq

Data coverage

Local Form 4 history268 transaction lines from 2021-04-21 to 2026-09-24
8 P purchase lines · 69 S sale lines · 191 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.